Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor
11 6월 2024 - 3:30AM
AllPennyStocks.com
CAR T-cell therapy has seen significant growth and much promise,
as it provides targeted and personalized treatment for patients
with certain types of cancer, particularly those that have
not...
To read the full story on AllPennyStocks.com, click
here.
SOHM (PK) (USOTC:SHMN)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
SOHM (PK) (USOTC:SHMN)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
SOHM Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More SOHM Inc (PK) News Articles
